First report of OXA-48 carbapenemase-producing Escherichia coli in Taiwan by unknown
POSTER PRESENTATION Open Access
First report of OXA-48 carbapenemase-producing
Escherichia coli in Taiwan
Y Jao1*, P-S Lee2, C-T Hung1, C-F Wang2, MH Hsieh1,3, C-Y Lin1,3, Y-H Chen1,3, P-L Lu2,3
From 3rd International Conference on Prevention and Infection Control (ICPIC 2015)
Geneva, Switzerland. 16-19 June 2015
Introduction
Carbapenems are the last-line antibiotic in treating
Enterobacteriaceae because its broad-spectrum antibac-
terial ability, high bactericidal activity and good stability
to b-lactamases. However, carbapenem-resistant Entero-
bacteriaceae (CRE) infection increased all over the world
in recent years. The challenge of carbapenems in treat-
ing Enterobacteriaceae is increasing.
Objectives
A 55-year old woman who had been diagnosed with
cancer and had received multiple courses of chemother-
apy in Vietnam, visited our hospital for a second opi-
nion in June 2014.
Left breast tumor with non-discharge necrotic tissue
was presented at admission. The laboratory examination
demonstrated WBC 6300/uL, Hb 12.1g/dL and PLT
103000/uL. Specimen from left breast wound grew
Escherichia coli, which resistant to carbapenems, broad-
spectrum b-lactams and fluoroquinolones. There was no
inflammation reaction caused by the pathogen. During
hospitalization, she did not receive antimicrobial therapy
effective to the pathogen.
Methods
We found that this Escherichia coli had the presentation
of carbapenemase via modified Hodge test. Polymerase
chain reaction and DNA sequencing was performed to
test if Carbapenemase (blaKPC, blaNDM, blaIPM, bla-
VIM, blaOXA) or b-lactamases (SH, TEM, OXA, GES,
CTX-M) presents.
Results
Resistance genes of blaOXA-48 and CTX-M-1-group were
found. Besides, this Escherichia coli also presented with
loss of outer membrane protein A and F. With multilocus
sequence typing (MLST) analysis, this Escherichia coli is
ST-405.
Conclusion
To our knowledge, this is the first OXA-48 carbapenemase
producing Escherichia coli isolated in Taiwan, though it’s
originated from Vietnam. It’s resistance profile is similar
to other OXA-48 carbapenemase producing Escherichia
coli isolated from Japan and France. According to this
finding, Escherichia coli acquiring OXA-48 carbapenemase
may had spread to Southeastern Asia. In order to prevent
the transmission of CRE, the detection of carbapenemase
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